摘要
我院于１９７７～１９８８年收治恶性淋巴瘤１６４例，随访１５６例，１、３、５年存活率分别为５７．１％、３３．３％和２８．８％，分析影响长期存活因素中，认为主要决定于治疗措施。以放、化疗结合并辅以中药、免疫治疗组的５年存活率最高，其５年存活率（４５．４％）明显高于单纯放疗组（２０．５％）及单纯化疗组（２７．７％）。何杰金氏淋巴瘤（ＨＤ）５年存活率明显高于非何杰金氏淋巴瘤（ＮＨＬ）。并认为综合治疗应以联合化疗为主，有计划地结合６０Ｃ。放疗及其他治疗措施为宜。死亡的主要原因是局部复发和远处转移。
From 1977 to 1988, 164 patients with malignant lymphoma were treated in our hospital,156 cases of them were followed up,and the one-year,three-year and five-year-survival rates are 57. 1% 33. 3% and 28. 8% respectively,Among the prognostic factors of the long-term survival,we regard the treating method as the most important one. The 5-year-survival rate in the group treated with the combination of radiotherapy and chemotherapy,and at the mean time with chinese medicine and immunity as assistant treatment,was the highest(45. 4%). It is much higher than the group treated with radiotherapy alone(20. 5% ),or with chemotherapy alone (27. 2%).The five-year-survival rate of the patients with Hodgkins Lymph-oma (HD) is much higher than that of those with Non-Hodgkin's Lymphoms (NHL). We also think that in the combined treatment compound chemotherapy shoud be selected first and it is suitable to combine with 60Co radiotherapy and other treatment in purpose. The main cause of death is local relapse and long-distance metastasis.
出处
《河南肿瘤学杂志》
1994年第1期46-49,共4页
Henan Journal of Oncology
关键词
长期存活
影响因素
淋巴肉瘤
治疗
malignant lymphoma, radiotherapy, chemotherapy, long-term survival, prognostic factors
